An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A short video claims three peptides — Selank, Semax and Epitalon — might change how we think about the brain and aging. It suggests these small protein-like molecules have effects on mood, cognition, and lifespan. The report is broad and sounds hopeful, but the title alone doesn’t tell us how strong the evidence is or where it comes from. Semax and Selank are man-made peptides developed in Russia. In plain terms, they’re tiny chains of amino acids designed to act like or influence natural brain chemicals. Semax is often described as boosting attention and memory by affecting brain signaling pathways. Selank is pitched as having anti-anxiety and mood-stabilizing effects. Epitalon (also written epithalon) is a different kind of peptide that’s linked to aging and the regulation of cellular clocks; researchers have tested it for effects on lifespan and cellular repair. None of these are everyday household medicines like aspirin — they’re experimental compounds with more research in animals and small clinical settings than in large, rigorous human trials. What the research actually shows is mixed and mostly early-stage. Semax and Selank have been studied in Russia and some small human trials for short-term effects on cognition, stress response and anxiety, with some positive signals but limited sample sizes and replication outside a few labs. Epitalon has some animal studies suggesting it might influence markers of aging and extend lifespan in certain species; a few human studies report changes in hormonal markers, but these studies are small and not definitive. The overall picture is promising in some niches, but far from proven. The title’s claim that they “could change how we think” is more speculative than confirmed science. Why this matters: if any of these peptides reliably improved mood, cognition or slowed aspects of aging, that would be a big deal for people struggling with anxiety, age-related memory decline, or those interested in longevity. They could offer new ways to treat brain health that aren’t traditional antidepressants or Alzheimer drugs. For curious individuals, researchers and biotech companies, these peptides are interesting leads worth following. For regular readers, it’s a reminder that new biological tools are being explored beyond well-known drugs like Ozempic. Caveats and risks are important. These compounds are not mainstream, widely approved treatments in most countries. Safety profiles aren’t fully established, long-term effects are unclear, and dosing standards are not well set. Some studies come from small or non-representative samples, and there can be publication or geographic bias in the literature. People should avoid self-experimenting with peptides bought online; quality and purity vary, and interactions with other medications are not well studied. If someone is considering these for health reasons, the sensible step is to consult a qualified medical professional and look for larger, well-controlled studies. Bottom line: Selank, Semax and Epitalon are intriguing experimental peptides with some early evidence for effects on mood, cognition and aging, but the science is preliminary and not yet a basis for routine use.
Source: YouTube